Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 3-4, 2009, Pages 241-248

  Janssens, Sandrien ^a   Anné, Michael ^a   Rombaut, Patrick ^a   Van den Mooter, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Itraconazole; Kollicoat IR; Modulated differential scanning calorimetry; Spray drying

Indexed keywords

ALCOHOL; CHLORIDE; DICHLOROMETHANE; DRUG CARRIER; ITRACONAZOLE; KOLLICOAT IR; POLYMER; UNCLASSIFIED DRUG; WATER;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SPRAY DRYING; X RAY POWDER DIFFRACTION;

ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DESICCATION; DRUG CARRIERS; ITRACONAZOLE; POLYVINYLS; POWDERS; SOLUBILITY; SOLVENTS; TEMPERATURE; X-RAY DIFFRACTION;

EID: 67349158352     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.02.020     Document Type: Article

References (25)

1. Branchu S., Rogueda P.G., Plumb A.P., and Cook W.G. A decision-support tool for the formulation of orally active, poorly soluble compounds. Eur. J. Pharm. Sci. 32 (2007) 128-139
2. Broman E., Khoo C., and Taylor L.S. A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug. Int. J. Pharm. 222 (2001) 139-151
3. Chawla G., and Bansal A.K. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Eur. J. Pharm. Sci. 32 (2007) 45-57
4. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersions. J. Pharm. Sci. 60 (1971) 1281-1302
5. Corrigan O.I. Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11 (1985) 697-724
6. Couchman P.R., and Karasz F.E. A classical thermodynamic discussion of the effect of composition on glass-transition temperatures. Macromolecules 11 (1978) 117-119
7. Fox T.G. Influence of diluent and of copolymer composition on the glass transition temperature of a polymer system. Bull. Am. Phys. Soc. 1 (1956) 123
8. Gordon S., and Taylor J.S. Ideal copolymers and the second-order transitions of synthetic rubbers. I. Non-crystalline copolymers. J. Appl. Chem. 2 (1952) 493-500
9. ®, in the formulation of solid dispersions of itraconazole. Eur. J. Pharm. Sci. 30 (2007) 288-294
10. Janssens S., Denivelle S., Rombaut P., and Van den Mooter G. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol 6000/hydroxypropylmethylcellulose 2910 E5 blends. Eur. J. Pharm. Sci. 35 (2008) 203-210
11. Janssens S., Nagels S., Novoa de Armas H., D'Autry W., Van Schepdael A., and Van den Mooter G. Formulation and characterization of ternary solid dispersions made up of itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur. J. Pharm. Biopharm. 69 (2008) 158-166
12. ®-innovation in instant release film coating. BASF ExAct 8 (2002) 4-5
13. ®. BASF ExAct 8 (2002) 2-3
14. Leuner C., and Dressman J.B. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Sci. 50 (2000) 47-60
15. Lipinsky C. Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 5 (2002) 82-85
16. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29 (2006) 278-287
17. Roovers J., and Toporowski P.M. Rheological study of miscible blends of 1,4-polybutadiene and 1,2-polybutadiene (63% 1,2). Macromolecules 25 (1992) 1096-1102
18. Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
19. Six K., Verreck G., Peeters J., Binnemans K., Berghmans H., Augustijns P., Kinget R., and Van den Mooter G. Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase. Thermochem. Acta 376 (2001) 175-181
20. Six K., Leuner C., Dressman J.B., Verreck G., Peeters J., Blaton N., Augustijns P., Kinget R., and Van den Mooter G. Thermal properties of hot-stage extrudates of itraconazole and Eudragit E100, phase separation and polymorphism. J. Therm. An. Cal. 68 (2002) 591-601
21. Six K., Verreck G., Peeters J., Brewster M., and Van den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93 (2004) 124-131
22. Stegemann S., Leveiller F., Franchi D., de Jong H., and Lindén H. When poor solubility becomes an issue: from early stage to proof of concept. Eur. J. Pharm. Sci. 31 (2007) 249-261
23. Vandecruys R., Peeters J., Verreck G., and Brewster M.E. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. Int. J. Pharm. 342 (2007) 168-175
24. Van den Mooter G., Weuts I., De Ridder T., and Blaton N. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int. J. Pharm. 316 (2006) 1-6
25. Wang X., Michoel A., and Van den Mooter G. Solid state characterisation of ternary solid dispersions composed of PVPVA 64, Myrj 64 and itraconazole. Int. J. Pharm. 303 (2005) 54-61